Title
Category
Credits
Event date
Cost
Cancer Screening in Primary Care - SPOC
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.50 ASRT
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Noelle Robertson, MD, CAQSM presents an evidence-based review of outpatient primary care screening for breast, colon, lung and prostate cancer.
Navigating Serious Illness with Palliative Care and Hospice
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.50 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
In this webinar, Jared Lowe, MD, HMDC dicusses serious illness and discuss strategies to support patients with a primary focus on reviewing the services of palliative care and hospice care.
Solid Organ Transplantation and Skin Cancer
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Webinar InformationWebinar Description
Next Generation Cancer Care Navigation
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
William Wood, MD, MPH will review ways to expand traditional clinic-based cancer navigation to population-based cancer navigation using a central navigation approach. We will discuss how this approach can foster equity in care delivery and outcomes, while incorporating new initiatives that promote quality improvement. We will also talk about how this work fits into the current national environment that surrounds cancer navigation, including the recent development of a learning community and of new proposed billing codes that support the delivery of navigation services.
ePROs Monitoring in Thoracic Surgery and Oncology Patients
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Symptom burden is high in thoracic surgery and oncology patients. Gita Mody, MD, MPH discusses the role of electronic patient-reported outcome (ePRO) remote monitoring systems to improve patients' survivorship care.
Role of Specialty Pharmacy
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Sonali Acharya, PharmD. will explain the role of specialty pharmacies. We will discuss accreditation requirements for specialty pharmacies, process to determine which medications are considered specialty and specifically the benefits of a healthcare system specialty pharmacy.
Let’s Take a BiTE Out of CRS and Neurotoxicity
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Immunotherapy has made tremendous progress as cancer-directed therapy has evolved, particularly in the field of T cell-engaging therapies. Common and serious side effects of these types of therapies include Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Join us as Bejal Kikani, MSN, FNP-BC, WHNP-BC, discusses the recognition, grading, and treatment of these toxicities.
Peritoneal Carcinomatosis: The Good, the Bad, and the Ugly
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Jeremiah 'Jig' Deneve, DO, FACS, provides an overview of the natural history, treatment, and outcome for peritoneal carcinomatosis.
CAR-T 101: Overview of CAR-T Therapy and Management of Toxicities
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Megan McElfresh, PA-C, will review chimeric antigen receptor therapy, associated side effects, and the treatment or prevention of side effects.
Lung Cancer Screening Essentials
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
This multidisciplinary Panel Presentation will describe the importance of CT-based lung cancer screening, indications and criteria for screening, the optimal structure and requirements of a screening program, and the current state of screening at UNC. We will present practical information relevant to providers who may order screening CT and/or may discuss screening with patients.

Pages